{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:52:10Z","timestamp":1791183130043,"version":"4.1.0"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1097\/wco.0b013e3283446f05","type":"journal-article","created":{"date-parts":[[2011,2,25]],"date-time":"2011-02-25T08:30:31Z","timestamp":1298622631000},"page":"146-153","source":"Crossref","is-referenced-by-count":117,"title":["Autoimmune epilepsies"],"prefix":"10.1097","volume":"24","author":[{"given":"Sarosh R","family":"Irani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian G","family":"Bien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethan","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210206","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1528-1167.2010.02522.x","article-title":"Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005\u20132009","volume":"51","author":"Berg","year":"2010","journal-title":"Epilepsia"},{"key":"R2-10-20210206","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1093\/brain\/awp187","article-title":"Frequency, prognosis and surgical treatment of structural abnormalities seen with magnetic resonance imaging in childhood epilepsy","volume":"132","author":"Berg","year":"2009","journal-title":"Brain"},{"key":"R3-10-20210206","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/jnnp.69.6.711","article-title":"Epilepsy: an autoimmune disease?","volume":"69","author":"Palace","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R4-10-20210206","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00281-009-0176-1","article-title":"Encephalitis and epilepsy","volume":"31","author":"Bauer","year":"2009","journal-title":"Semin Immunopathol"},{"key":"R5-10-20210206","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/WCO.0b013e32833735fe","article-title":"The growing recognition of immunotherapy-responsive seizure disorders with autoantibodies to specific neuronal proteins","volume":"23","author":"Vincent","year":"2010","journal-title":"Curr Opin Neurol"},{"key":"R6-10-20210206","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1212\/01.wnl.0000276946.08412.ef","article-title":"Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy","volume":"69","author":"Bien","year":"2007","journal-title":"Neurology"},{"key":"R7-10-20210206","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/brain\/awh077","article-title":"Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis","volume":"127","author":"Vincent","year":"2004","journal-title":"Brain"},{"key":"R8-10-20210206","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1212\/01.WNL.0000122648.19196.02","article-title":"Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody","volume":"62","author":"Thieben","year":"2004","journal-title":"Neurology"},{"key":"R9-10-20210206","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and Contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"R10-10-20210206","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1212\/01.wnl.0000326572.93762.51","article-title":"Immunotherapy-responsive seizure-like episodes with potassium channel antibodies","volume":"71","author":"Irani","year":"2008","journal-title":"Neurology"},{"key":"R11-10-20210206","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1212\/01.wnl.0000187129.66353.13","article-title":"Serum antibodies in epilepsy and seizure-associated disorders","volume":"65","author":"McKnight","year":"2005","journal-title":"Neurology"},{"key":"R12-10-20210206","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.eplepsyres.2006.06.003","article-title":"Antibodies to voltage-gated potassium channels in epilepsy","volume":"71","author":"Majoie","year":"2006","journal-title":"Epilepsy Res"},{"key":"R14-10-20210206","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1097\/JTO.0b013e3181f23f04","article-title":"Caspr2 antibodies in patients with thymomas","volume":"5","author":"Vincent","year":"2010","journal-title":"J Thorac Oncol"},{"key":"R15-10-20210206","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S1474-4422(10)70137-X","article-title":"Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series","volume":"9","author":"Lai","year":"2010","journal-title":"Lancet Neurol"},{"key":"R16-10-20210206","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1528-1167.2009.02287.x","article-title":"Adult-onset drug-refractory seizure disorder associated with antivoltage-gated potassium-channel antibody","volume":"51","author":"Barajas","year":"2010","journal-title":"Epilepsia"},{"key":"R17-10-20210206","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1001\/archneur.65.10.1341","article-title":"Voltage-gated potassium channel autoimmunity mimicking Creutzfeldt-Jakob disease","volume":"65","author":"Geschwind","year":"2008","journal-title":"Arch Neurol"},{"key":"R18-10-20210206","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol"},{"key":"R19-10-20210206","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"key":"R20-10-20210206","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/brain\/awq113","article-title":"N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly nonparaneoplastic disorder of both sexes","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"R21-10-20210206","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/ana.21756","article-title":"Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents","volume":"66","author":"Florance","year":"2009","journal-title":"Ann Neurol"},{"key":"R22-10-20210206","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1001\/archneurol.2009.5","article-title":"Diagnostic value of N-methyl-D-aspartate receptor antibodies in women with new-onset epilepsy","volume":"66","author":"Niehusmann","year":"2009","journal-title":"Arch Neurol"},{"key":"R23-10-20210206","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1212\/WNL.0b013e3181f8831a","article-title":"Anti-NMDA receptor encephalitis causing prolonged nonconvulsive status epilepticus.","volume":"75","author":"Johnson","year":"2010","journal-title":"Neurology"},{"key":"R24-10-20210206","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1523\/JNEUROSCI.0167-10.2010","article-title":"Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis","volume":"30","author":"Hughes","year":"2010","journal-title":"J Neurosci"},{"key":"R25-10-20210206","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/ana.21807","article-title":"NMDA receptor antibodies in pediatric dyskinetic encephalitis lethargica","volume":"66","author":"Dale","year":"2009","journal-title":"Ann Neurol"},{"key":"R26-10-20210206","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/jnnp.2006.093096","article-title":"Course and outcome of acute limbic encephalitis with negative voltage-gated potassium channel antibodies","volume":"78","author":"Samarasekera","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R27-10-20210206","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","article-title":"Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen","volume":"9","author":"Lancaster","year":"2010","journal-title":"Lancet Neurol"},{"key":"R28-10-20210206","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.21589","article-title":"AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location","volume":"65","author":"Lai","year":"2009","journal-title":"Ann Neurol"},{"key":"R29-10-20210206","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/brain\/awh415","article-title":"Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement","volume":"128","author":"Bien","year":"2005","journal-title":"Brain"},{"key":"R30-10-20210206","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/brain\/awf176","article-title":"The natural history of Rasmussen's encephalitis","volume":"125","author":"Bien","year":"2002","journal-title":"Brain"},{"key":"R31-10-20210206","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/ana.10100","article-title":"Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis","volume":"51","author":"Bien","year":"2002","journal-title":"Ann Neurol"},{"key":"R32-10-20210206","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ana.21148","article-title":"Astrocytes are a specific immunological target in Rasmussen's encephalitis","volume":"62","author":"Bauer","year":"2007","journal-title":"Ann Neurol"},{"key":"R33-10-20210206","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/brain\/awp003","article-title":"CD8+ T cell clones dominate brain infiltrates in Rasmussen encephalitis and persist in the periphery","volume":"132","author":"Schwab","year":"2009","journal-title":"Brain"},{"key":"R34-10-20210206","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/nrneurol.2009.98","article-title":"A case of Rasmussen encephalitis treated with rituximab","volume":"5","author":"Thilo","year":"2009","journal-title":"Nat Rev Neurol"},{"key":"R35-10-20210206","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1093\/brain\/awn183","article-title":"Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association","volume":"131","author":"Saiz","year":"2008","journal-title":"Brain"},{"key":"R36-10-20210206","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1528-1167.2009.02325.x","article-title":"Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy","volume":"51","author":"Liimatainen","year":"2010","journal-title":"Epilepsia"},{"key":"R37-10-20210206","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jneuroim.2009.04.010","article-title":"Autoantibodies to glutamic acid decarboxylase (GAD) in focal and generalized epilepsy: a study on 233 patients","volume":"211","author":"Errichiello","year":"2009","journal-title":"J Neuroimmunol"},{"key":"R38-10-20210206","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/ana.21917","article-title":"Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis","volume":"67","author":"Malter","year":"2010","journal-title":"Ann Neurol"},{"key":"R39-10-20210206","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1111\/j.1468-1331.2009.02839.x","article-title":"Refractory generalized seizures and cerebellar ataxia associated with anti-GAD antibodies responsive to immunosuppressive treatment","volume":"17","author":"Nociti","year":"2010","journal-title":"Eur J Neurol"},{"key":"R40-10-20210206","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jneuroim.2008.05.015","article-title":"Nonparaneoplastic limbic encephalitis associated with antiglutamic acid decarboxylase antibodies","volume":"199","author":"Mat\u00e0","year":"2008","journal-title":"J Neuroimmunol"},{"key":"R41-10-20210206","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1528-1167.2007.01500.x","article-title":"Cyclophosphamide for anti-GAD antibody-positive refractory status epilepticus","volume":"49","author":"Kanter","year":"2008","journal-title":"Epilepsia"},{"key":"R42-10-20210206","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1111\/j.1528-1167.2010.02644.x","article-title":"Autoantibodies to glutamate acid decarboxylase in epilepsy patients are associated with a low cortical GABA levels","volume":"51","author":"Stagg","year":"2010","journal-title":"Epilepsia"},{"key":"R43-10-20210206","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1600-0404.2009.01198.x","article-title":"Acute encephalitis with refractory, repetitive partial seizures (AERRPS): a peculiar form of childhood encephalitis","volume":"121","author":"Sakuma","year":"2010","journal-title":"Acta Neurol Scand"},{"key":"R44-10-20210206","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/j.1528-1167.2010.02535.x","article-title":"Febrile infection-related epilepsy syndrome (FIRES): a nonencephalitic encephalopathy in childhood","volume":"51","author":"Van Baalen","year":"2010","journal-title":"Epilepsia"},{"key":"R45-10-20210206","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.eplepsyres.2006.01.002","article-title":"Devastating epileptic encephalopathy in school-aged children (DESC): a pseudo-encephalitis","volume":"69","author":"Mikaeloff","year":"2006","journal-title":"Epilepsy Res"},{"key":"R46-10-20210206","doi-asserted-by":"crossref","first-page":"417","DOI":"10.47102\/annals-acadmedsg.V34N7p417","article-title":"The NORSE (new-onset refractory status epilepticus) syndrome: defining a disease entity","volume":"34","author":"Wilder-Smith","year":"2005","journal-title":"Ann Acad Med Singapore"},{"key":"R47-10-20210206","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/brain\/84.4.680","article-title":"The acute encephalopathies of obscure origin in infants and children","volume":"84","author":"Lyon","year":"1961","journal-title":"Brain"},{"key":"R48-10-20210206","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jns.2008.10.007","article-title":"Cryptogenic New Onset Refractory Status Epilepticus (NORSE) in adults-Infectious or not?","volume":"277","author":"Costello","year":"2009","journal-title":"J Neurol Sci"},{"key":"R49-10-20210206","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1212\/01.wnl.0000312275.04260.a0","article-title":"Clinical spectrum of voltage-gated potassium channel autoimmunity","volume":"70","author":"Tan","year":"2008","journal-title":"Neurology"}],"container-title":["Current Opinion in Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WCO.0b013e3283446f05","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:35:11Z","timestamp":1740962111000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00019052-201104000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/wco.0b013e3283446f05","relation":{},"ISSN":["1350-7540"],"issn-type":[{"value":"1350-7540","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}